The main aim of the present study was to identify the long-term effects of continuous positive airway pressure (CPAP) treatment in patients co-affected by obstructive sleep apnea syndrome (OSAS) and mild cognitive impairment (MCI) or dementia due to Alzheimer’s disease (ADD).
This retrospective multicentre study included patients affected by MCI or ADD, diagnosed according to the core clinical and biomarkers criteria, and presenting comorbid OSAS. Only patients performing at least a 1-year visit during their follow-up to monitor cognitive deterioration and adherence with CPAP treatment were included. Both Mini-Mental State Examination (MMSE) and clinical dementia rating scale (CDR) were conducted during the baseline and the follow-up visits.
Twenty-four patients were included in the study and were distributed according to the diagnosis in MCI (n = 8) or ADD (n = 16). There were no significant differences in the variables analysed at baseline between the CPAP non-adherent and CPAP adherent patients. In the whole group, a significant decrease was found in MMSE scores, and a significant increase was found in CDR scores between baseline and follow-up. No longitudinal changes in ESS scores were statistically significant from baseline to follow-up. A significant difference was found for the mean score change of the CDR since CPAP non-adherent patients showed a higher mean change of CDR compared to CPAP adherent patients. No significant differences were found for the mean change of MMSE.
These findings highlight the clinical potential of treating OSAS with CPAP to delay cognitive deterioration in patients with MCI or ADD.
This is a preview of subscription content, access via your institution.
We’re sorry, something doesn't seem to be working properly.
Please try refreshing the page. If that doesn't work, please contact support so we can address the problem.
Heinzer R, Vat S, Marques-Vidal P, Marti-Soler H, Andries D, Tobback N, Mooser V, Preisig M, Malhotra A, Waeber G, Vollenweider P, Tafti M, Haba-Rubio J (2015) Prevalence of sleep-disordered breathing in the general population: the HypnoLaus study. Lancet Respir Med. Elsevier Ltd 3:310–318. https://doi.org/10.1016/S2213-2600(15)00043-0
Guilleminault C (2005) Clinical features and evaluation of obstructive sleep apnea-hyponea syndrome. Princ Pract Sleep Med. Elsevier Saunders Co.
Gehrman PR, Martin JL, Shochat T, Nolan S, Corey-Bloom J, Ancoli-Israel S (2003) Sleep-disordered breathing and agitation in institutionalized adults with Alzheimer disease. Am J Geriatr Psychiatry. American Association for Geriatric Psychiatry 11:426–433. https://doi.org/10.1097/00019442-200307000-00005
Díaz-Román M, Pulopulos MM, Baquero M, Salvador A, Cuevas A, Ferrer I, Ciopat O, Gómez E (2021) Obstructive sleep apnea and Alzheimer’s disease-related cerebrospinal fluid biomarkers in mild cognitive impairment. Sleep 44(1):zsaa133. https://doi.org/10.1093/sleep/zsaa133
Liguori C, Maestri M, Spanetta M, Placidi F, Bonanni E, Mercuri NB, Guarnieri B (2021) Sleep-disordered breathing and the risk of Alzheimer’s disease. Sleep Med Rev. Elsevier Ltd 55:1–16. https://doi.org/10.1016/j.smrv.2020.101375
Engleman H, Joffe D (1999) Neuropsychological function in obstructive sleep apnoea. Sleep Med Rev 3:59–78
Richards KC, Gooneratne N, Dicicco B, Hanlon A, Moelter S, Onen F, Wang Y, Sawyer A, Weaver T, Lozano A, Carter P, Johnson J (2019) CPAP Adherence may slow 1-year cognitive decline in older adults with mild cognitive impairment and apnea. J Am Geriatr Soc 67:558–564
Cooke JR, Ayalon L, Palmer BW, Loredo JS, Corey-Bloom J, Natarajan L, Liu L, Ancoli-Israel S (2009) Sustained use of CPAP slows deterioration of cognition, sleep, and mood in patients with Alzheimer’s disease and obstructive sleep apnea: a preliminary study. J Clin Sleep Med 5:305–309
Cooke JR, Ancoli-Israel S, Liu L, Loredo JS, Natarajan L, Palmer BS, He F, Corey-Bloom J (2009) Continuous positive airway pressure deepens sleep in patients with Alzheimer’s disease and obstructive sleep apnea. Sleep Med. Elsevier B.V. 10:1101–1106. https://doi.org/10.1016/j.sleep.2008.12.016
Chong MS, Ayalon L, Marler M, Loredo JS, Corey-Bloom J, Palmer BW, Liu L, Ancoli-Israel S (2006) Continuous positive airway pressure reduces subjective daytime sleepiness in patients with mild to moderate Alzheimer’s disease with sleep disordered breathing. J Am Geriatr Soc 54:777–781. https://doi.org/10.1111/j.1532-5415.2006.00694.x
Liguori C, Mercuri NB, Izzi F, Romigi A, Cordella A, Sancesario G, Placidi F (2017) Obstructive sleep apnea is associated with early but possibly modifiable Alzheimer’s disease biomarkers changes. Sleep 40:1–10. https://academic.oup.com/sleep/article-lookup, https://doi.org/10.1093/sleep/zsx011
Ancoli-Israel S, Palmer BW, Cooke JR, Corey-Bloom J, Fiorentino L, Natarajan L, Liu L, Ayalon L, He F, Loredo JS (2008) Cognitive effects of treating obstructive sleep apnea in Alzheimer’s disease: a randomized controlled study. J Am Geriatr Soc 56:2076–2081
Troussière AC, Charley CM, Salleron J, Richard F, Delbeuck X, Derambure P, Pasquier F, Bombois S (2014) Treatment of sleep apnoea syndrome decreases cognitive decline in patients with Alzheimer’s disease. J Neurol Neurosurg Psychiatry 85:1405–1408
Jorge C, Targa A, Benítez ID, Dakterzada F, Torres G, Minguez O, Carnes A, Pujol M, Gibert A, López R, Gaeta AM, Dalmases M, Farré R, Sánchez-de-la-Torre M, Barbé F, Piñol-Ripoll G (2020) Obstructive sleep apnoea and cognitive decline in mild-to-moderate Alzheimer’s disease. Eur Respir J 56:520–523. https://doi.org/10.1183/13993003.00523-2020
Skiba V, Novikova M, Suneja A, McLellan B, Schultz L (2020) Use of positive airway pressure in mild cognitive impairment to delay progression to dementia. J Clin Sleep Med 16:863–870. https://doi.org/10.5664/jcsm.8346
Osorio RS, Gumb T, Pirraglia E, Varga AW, Lu SE, Lim J, Wohlleber ME, Ducca EL, Koushyk V, Glodzik L, Mosconi L, Ayappa I, Rapoport DM, De Leon MJ (2015) Sleep-disordered breathing advances cognitive decline in the elderly. Neurology 84:1964–1971
Wang Y, Cheng C, Moelter S, Fuentecilla JL, Kincheloe K, Lozano AJ, Carter P, Gooneratne N, Richards KC (2020) One year of continuous positive airway pressure adherence improves cognition in older adults with mild apnea and mild cognitive impairment. Nurs Res 69:157–164
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
Informed consent was waived due to the retrospective nature of the present study
Conflict of interest
The authors declare no competing interests.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Liguori, C., Cremascoli, R., Maestri, M. et al. Obstructive sleep apnea syndrome and Alzheimer’s disease pathology: may continuous positive airway pressure treatment delay cognitive deterioration?. Sleep Breath (2021). https://doi.org/10.1007/s11325-021-02320-4
- Obstructive sleep apnea syndrome
- Alzheimer’s disease
- Continuous positive airway pressure treatment
- Mild cognitive impairment